Pathology Oncology Research

, Volume 10, Issue 4, pp 219–224 | Cite as

Subependymal giant cell astrocytoma — a clinicopathological study of 23 cases with special emphasis on histogenesis

  • Mehar Chand Sharma
  • Angela Mercy Ralte
  • Shailesh Gaekwad
  • Vani Santosh
  • S. K. Shankar
  • Chitra Sarkar


Subependymal giant cell astrocytomas (SEGAs) are relatively rare tumors but occur commonly in the setting of the familial syndrome of tuberous sclerosis complex (TSC). In view of its varied morphology, i.e. resemblance to astrocytic and ganglion cells, its histogenesis remains controversial. We studied 23 cases of SEGA, 19 from our own institute and 4 from NIMHANS, Bangalore. These 19 cases of SEGAs were collected over a period of 23 years (1979 to 2001), and accounted for 0.16% of intracranial tumors and 0.51% of all gliomas reported at our center. The majority of patients presented with visual disturbances (19÷23, 82.6%) in the form of decreased vision (60.8%) and blindness (21.7%), generalized tonic clonic seizures (43.4%) and focal motor seizures (4.37%). Age ranged from 4 to 37 years (mean 13.2 years) with male predominance (M:F 2.2:1), and the duration of symptoms varied from 1 month to 96 months (mean 17.2 months). Lateral ventricular involvement was the most common site (91.3%), followed by the third ventricle (8.6%). Nine patients (39.1%) had stigmata of tuberous sclerosis (6 at the time of diagnosis and 3 in the follow-up period). Two patients died due to surgical complications, while the rest were alive and well in the follow-up period ranging from 3 to 264 months (mean 37.1 months). Two patients experienced recurrences, one two years and another 22 years after surgery. Microscopic examination showed varied histology consisting of sweeping bundles of spindle cells, gemistocyte and ganglion-like cells with interspersed inflammatory cell component. The inflammatory cell component on special staining turned out to be an admixture of mast cells and T lymphocytes. Six cases showed areas of necrosis and/or mitosis, but were not indicative of aggressive nature of this tumor. Immunoreactivity for GFAP, NF, S-100, NSE and synaptophysin indicates that this is a hybrid tumor with glial and neuronal differentiation. None of the tumors was immunopositive for HMB-45. The significance of the presence of T lymphocytes and mast cells is not clear. It could be related to tumor immunology and may indicate a favorable prognosis.


tuberous sclerosis SEGA epilepsy lateral ventricle tumor immunohistochemistry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shepherd CW, Scheithauer BW, Gomez MR, et al Subependymal giant cell astrocytoma: a clinical, pathological and flow cytometric study. Neurosurg 28: 868–864, 1991Google Scholar
  2. 2.
    Chow CW, Klug GL, Lewis EA: Subependymal giant cell astrocytoma in children: An unusual discrepancy between histological and clinical features. J Neurosurg 68: 880–883, 1988PubMedGoogle Scholar
  3. 3.
    Bonnin JM, Rubinstein LJ, Papasozomenos SC andMarangos PJ: Subependymal giant cell astrocytomas. Significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol 62: 185–193, 1984PubMedCrossRefGoogle Scholar
  4. 4.
    Fuziwara S, Takaki T, Hikita T, Nishio S: Subependymal giant cell astrocytoma associated with tuberous sclerosis: do subependymal nodules grow? Child’s nervous system 5: 43–44, 1989CrossRefGoogle Scholar
  5. 5.
    Morimoto K, Mogami H: Sequential CT study of subependymal giant cell astrocytoma associated with tuberous sclerosis: case report. J Neurosurg 65: 874–877, 1986PubMedGoogle Scholar
  6. 6.
    Lopes MBS, Altermatt HJ, Scheithauer BW, et al: Immunohistochemical characterisation of subependymal giant cell astrocytomas. Acta Neuropathol 91: 368–375, 1996PubMedCrossRefGoogle Scholar
  7. 7.
    Bender BL, Yunis EJ: Central nervous system pathology of tuberous sclerosis in children. Ultrastruct Pathol 1: 287–299, 1980PubMedCrossRefGoogle Scholar
  8. 8.
    Halmagyi GM, Bignold LP, Allospi JP: Recurrent subependymal giant cell astrocytoma in the absence of tuberous sclerosis. J Neurosurg 50: 106–109, 1979PubMedGoogle Scholar
  9. 9.
    Sima AAF, Robertson DM: Subependymal giant cell astrocytoma. Case report with ultrastructural study. J Neurosurg 50: 240–245, 1979PubMedGoogle Scholar
  10. 10.
    Trombley IK, Mirra SS: Ultrastructure of tuberous sclerosis: cortical tuber and subependymal tumor. Ann Neurol 9: 174–181, 1981PubMedCrossRefGoogle Scholar
  11. 11.
    Bancel B, Belin MF, Meiniel A, et al: Contribution al’etude de l’histogenese des gliomes sous ependymaires de la sclerose tubereuse de Bourneville. Ann Pathol 10: 109–116, 1990PubMedGoogle Scholar
  12. 12.
    Iwasaki Y, Yoshikawa H, Sasaki M, et al: Clinical and immunohistochemical studies of subependymal giant cell astrocytoma associated with tuberous sclerosis. Brain Dev 12: 478–481, 1990PubMedGoogle Scholar
  13. 13.
    Stefanssan K, Wollmann RL: Distribution of neuronal specific protein 14-3.2 in central nervous system lesions of tuberous sclerosis. Acta Neuropathol (Berl) 53: 113–117, 1981CrossRefGoogle Scholar
  14. 14.
    Nakamura S, Tsubokawa T: Ultrastructure of subependymal giant cell astrocytoma associated with tuberous sclerosis. J Clin Electron Microscope 20: 5–6, 1987Google Scholar
  15. 15.
    Bonetti F, Chiodera PL, Pea M, et al: Transbronchial biopsy in lymphangiomyomatosis of the lung: HMB-45 for diagnosis. Am J Surg Pathol 17:1092–1102, 1993PubMedCrossRefGoogle Scholar
  16. 16.
    Gyure KA, Hart WR, Kennedy AW: Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Int J Gynecol Pathol 14: 344–351, 1995PubMedCrossRefGoogle Scholar
  17. 17.
    Pea M, Bonetti F, Zamboni G, et al: Melanocyte marker HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 23: 185–188, 1991PubMedCrossRefGoogle Scholar
  18. 18.
    Weeks DA, Chase DR, Malott RL, et al: HMB-45 staining in angiomyolipoma, cardiac rhabdomyoma, other mesenchymal processes and tuberous sclerosis associated brain lesions. Int J Surg Pathol 1:191–198, 1994CrossRefGoogle Scholar
  19. 19.
    Al-Saleem T, Wessner LL, Scheithauer BW, et al: Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83: 2208–2216, 1988CrossRefGoogle Scholar
  20. 20.
    Kingsley DPE, Kendall BE, Fitz CR: Tuberous sclerosis: A clinico-radiological evaluation of 110 cases with particular reference to atypical presentation. Neuroradiology 28: 38–46, 1986PubMedCrossRefGoogle Scholar
  21. 21.
    Boesel CP, Paulson GW, Kosnik EJ, Earle KM: Brain hamartomas and tumors associated with tuberous sclerosis. Neurosurgery 4: 410–417, 1979PubMedCrossRefGoogle Scholar
  22. 22.
    Padmalatha C, Harsuff RC, Ganick D, Hafez GR: Glioblastoma multiforme with tuberous sclerosis. Arch Lab Med 105: 645–650, 1980Google Scholar
  23. 23.
    Brown JM: Tuberous sclerosis with malignant astrocytoma. Med JAustr 1:811–814, 1975.CrossRefGoogle Scholar
  24. 24.
    Medhkour A, Traul D, Husain M: Neonatal subependymal giant cell astrocytoma. Ped Neurosurg 36: 271–274, 2002CrossRefGoogle Scholar
  25. 25.
    Gyure KA, Prayson RA: Subependymal giant cell astrocytoma: A clinicopathologic study with HMB-45 and MIB-1 immunohistochemical analysis. Mod Pathol 10: 313–317, 1997PubMedGoogle Scholar
  26. 26.
    Bacchi CE, Bonetti F, Pea M, et al: HMB-45: a review. Appl Immunohistochem 4: 73–85, 1996Google Scholar

Copyright information

© Arányi Lajos Foundation 2004

Authors and Affiliations

  • Mehar Chand Sharma
    • 1
  • Angela Mercy Ralte
    • 1
  • Shailesh Gaekwad
    • 1
    • 2
  • Vani Santosh
    • 1
    • 3
  • S. K. Shankar
    • 1
    • 3
  • Chitra Sarkar
    • 1
  1. 1.Department of PathologyAll India Institute of Medical SciencesNew Delhi
  2. 2.Department of NeuroradiologyAIIMSNew Delhi
  3. 3.Department of NeuropathologyNational Institute of Mental Health and Neurological SciencesBangaloreIndia

Personalised recommendations